Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.
Read on to learn more about your treatment options and outlook if you have platinum-resistant endometrial cancer. Are there treatments for platinum-resistant endometrial cancer? Your doctor may ...
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...
1d
News Medical on MSNShort-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effectiveIn a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...
Uterine fibroids are non-cancerous growths that can cause heavy bleeding fatigue and pelvic pain impacting daily life While ...
"To date, beyond chemotherapy, there have been limited treatment options for women with advanced, recurrent endometrial cancer in England," said Dr Susana Banerjee, consultant medical oncologist ...
Treatment plans for atypical uterine bleeding will depend on individual ... such as heart disease, breast cancer, and more. After doctors control initial bleeding, some people may continue with ...
a multiplex immunofluorescence assay for the identification of endometrial cancer patients who may benefit from ACR-368 treatment. The designation reflects the FDA’s determination that the ...
which represent approximately 75% of patients diagnosed with endometrial cancer and who have limited treatment options. Also Read: GSK Highlights New Approvals, Vaccine Momentum At JPMorgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results